Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

malondialdehyde; oxidative stress; new-onset diabetes; renal transplantation; BK virus; BK virus nephropathy; kidney allograft; transplantation; Alport syndrome; children; autosomal dominant polycystic kidney disease; epidemiology; hospitalization; kidney transplantation; subarachnoid hemorrhage; malignancy; post-transplant malignancy; renal cell carcinoma; meta-analysis; systematic reviews; tacrolimus; C/D-ratio; pharmacokinetics; opportunistic infection; allograft survival; urological complications; ureteric stent; urinary tract infection; timing of removal; living donor; ethnicity; age; obesity; genetic relationship donor/recipient; atypical hemolytic uremic syndrome; eculizumab; glucose intolerance; insulin secretion; insulin resistance; oral glucose tolerance test; healthy subject; hyperchloremia; kidney graft dysfunction; living donor kidney transplantation; Uropathogenic E. coli; UPEC; phylogeny; genomics; antibiotic resistance; virulence traits; night-time renal transplantation; graft survival; patient survival/outcome; surgical complications; acute rejection; lymphocyte; CD45RC; Belatacept; cardiovascular high risk; outcome; machine perfusion; organ preservation; temperature; hypothermic; normothermic; transplant; proton-pump inhibitors; iron; iron deficiency; polyomavirus; BKV; kidney; glomerulus; BKVAN; nephropathy; fluid management; delayed graft function; goal-directed fluid therapy; calcineurin inhibitor nephrotoxcity; C/D ratio; tacrolimus metabolism; ADPKD; native nephrectomy; patient outcome; perioperative complications; epidermal growth factor; creatinine; graft failure; renal transplantation.; new onset diabetes after renal transplantation; single nucleotide polymorphisms; n/a; urinary biomarkers; α-GST; π-GST; nephrotoxicity; urinary excretion of N1-methylnicotinamide; mortality; niacin status; dietary intake; tryptophan; vitamin B3; Kidney transplant; vitamin C; cancer mortality; oxidative stress.; mycophenolic acid; immunosuppression; plasmapheresis; oxalate; hyperoxaluria; kidney transplant recipients; post-transplantation diabetes mellitus; all-cause mortality; cardiovascular mortality; infectious mortality; magnesium; hypomagnesaemia; cancer; kidney transplant; survival; living kidney donation; living-donor kidney transplantation; beliefs; inequity; ischemia reperfusion injury; innate immune system; adaptive immune system; apoptosis; necrosis; hypoxic inducible factor; endothelial dysfunction; proton pump inhibitor; transplant rejection; GFR; insulin-like growth factor 1; growth hormone; muscle mass; patient survival; physical activity; renal transplant recipients; kidney transplant (KT); donor-specific antibodies (DSA); C3d-binding assay; antibody-mediated rejection (AMR); arsenic; diet; fish consumption; post-transplant diabetes mellitus; N1-methyl-2-pyridone-5-carboxamide; N1-methylnicotinamide; urinary excretion; kidney function; biomarker; branched chain amino acids; posttransplant diarrhea; methanogenesis; Methanosphaera stadtmanae; mucins; sulfate-reducing bacteria; acute humoral rejection; first-line therapy; outcomes; proteasome inhibitor; renal transplant; transplant recipients; calcineurin inhibitors; FK506; pharmacokinetic; fast tacrolimus metabolizers